Liposarcoma staging: Difference between revisions
Jump to navigation
Jump to search
Line 11: | Line 11: | ||
! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Primary Tumor (T)}} | ! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Primary Tumor (T)}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: 50px;" | Tx | ||
| style="padding: 5px 5px; background: #F5F5F5;; width: | | style="padding: 5px 5px; background: #F5F5F5;; width: 300px;" | Tumor cannot be assessed. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;"|T0 | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;"|T0 | ||
Line 42: | Line 42: | ||
|} | |} | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: | {| style="border: 0px; font-size: 90%; margin: 3px; width: 350px;" align=center | ||
|valign=top| | |valign=top| | ||
|+ | |+ | ||
! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Lymph Nodes (N)}} | ! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Lymph Nodes (N)}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: 50px;" |NX | ||
| style="padding: 5px 5px; background: #F5F5F5;; width: | | style="padding: 5px 5px; background: #F5F5F5;; width: 300px;" | Lymph nodes cannot be assessed. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |N0 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | No regional lymph node involvement. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |N1 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Regional lymph node involvement. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Table adapted from National Cancer Institute <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small> | | style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Table adapted from National Cancer Institute <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small> | ||
|} | |} | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: | {| style="border: 0px; font-size: 90%; margin: 3px; width: 350px;" align=center | ||
|valign=top| | |valign=top| | ||
|+ | |+ | ||
! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Metastasis (M)}} | ! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Metastasis (M)}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: 50px;" | M0 | ||
| style="padding: 5px 5px; background: #F5F5F5;; width: | | style="padding: 5px 5px; background: #F5F5F5;; width: 300px;" | No distant metastasis | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |M1 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | Distant metastasis | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Table adapted from National Cancer Institute <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small> | | style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Table adapted from National Cancer Institute <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small> |
Revision as of 14:42, 19 September 2014
Liposarcoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Liposarcoma staging On the Web |
American Roentgen Ray Society Images of Liposarcoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
Staging
Primary Tumor (T) | |
---|---|
Tx | Tumor cannot be assessed. |
T0 | No evidence of primary tumor. |
T1 | Tumor ≤ 5 cm |
|
Superficial tumor (not invading the fascia) |
|
Deep tumor |
T2 | Tumor > 5 cm |
|
Superficial tumor (not invading the fascia) |
|
Deep tumor |
Table adapted from National Cancer Institute [1] |
Lymph Nodes (N) | |
---|---|
NX | Lymph nodes cannot be assessed. |
N0 | No regional lymph node involvement. |
N1 | Regional lymph node involvement. |
Table adapted from National Cancer Institute [1] |
Metastasis (M) | |
---|---|
M0 | No distant metastasis |
M1 | Distant metastasis |
Table adapted from National Cancer Institute [1] |
References